Author:
Qi Yan,Lin Wu-Qiang,Liao Bin,Chen Jia-Wei,Chen Ze-Song
Abstract
AbstractTo investigate the value of metagenomic next-generation sequencing (mNGS) in acute leukemia (AL) patients with febrile neutropenia (FN). We retrospectively reviewed 37 AL patients with FN and compared the results of mNGS with blood culture (BC) and the clinical features of the mNGS-positive group and the mNGS-negative group. A total of 14 detected pathogens were the final clinical diagnosis, of which 9 strains were detected only by mNGS and 5 strains were detected by both mNGS and BC. The top pathogens were Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. A total of 67.57% (25/37) were bacterial infections, and 2.7% (1/37) were fungal or viral infections. The diagnostic positivity rate of mNGS (25/37, 67.6%) was significantly higher than that of BC (7/37, 18.9%), and the difference was statistically significant (p < 0.05). Then, we explored the clinical distinction between the mNGS-positive group and the mNGS-negative group, and 3 features were filtered, including lymphocyte count (LY), creatinine levels (Cr), and white blood cell count (WBC). Our study demonstrated that early implementation of mNGS can effectively improve the efficacy of pathogen detection in AL patients with FN. The higher diagnostic positivity rate and the ability to detect additional pathogens compared to BC made mNGS a valuable tool in the management of infectious complications in this patient population. Furthermore, the identified clinical features associated with mNGS results provided additional insights for the clinical indication of infection in AL patients with FN.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Boeriu, E. et al. Diagnosis and management of febrile neutropenia in pediatric oncology patients-a systematic review. Diagn. (Basel) 12, 142. https://doi.org/10.3390/diagnostics12081800 (2022).
2. Escrihuela-Vidal, F., Laporte, J., Albasanz-Puig, A. & Gudiol, C. Update on the management of febrile neutropenia in hematologic patients. Rev. Esp. Quimioter. 32(Suppl 2), 55–58 (2019).
3. Nucci, M. How I treat febrile neutropenia. Mediterr. J. Hematol. Infect. Dis. 13, e2021025. https://doi.org/10.4084/MJHID.2021.025 (2021).
4. Benamu, E. et al. Plasma microbial cell-free DNA Next-generation sequencing in the diagnosis and management of febrile neutropenia. Clin. Infect. Dis. 74, 1659–1668. https://doi.org/10.1093/cid/ciab324 (2022).
5. Garnica, M., Pierrotti, L. C., Oliveira, P. V., Mazzi, M. & Chebabo, A. Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia. Braz. J. Infect. Dis. 25, 101548. https://doi.org/10.1016/j.bjid.2021.101548 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献